Type II mutations cause a partial loss of NCC function in which the cotransporter is trafficked to the cell surface but has an impaired insertion in the plasma membrane.
Type II mutations result in a partial loss of NCC function, leading to the cotransporter being transported to the cell surface but with impaired insertion into the plasma membrane.